LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,857,288 | -53.7% | 16,909,720 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $53,669,665 | +78.2% | 16,877,253 | +32.3% | 0.00% | 0.0% |
| Q1 2023 | $30,111,530 | -31.1% | 12,759,123 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $43,691,569 | -52.0% | 12,591,230 | +1.5% | 0.00% | -66.7% |
| Q3 2022 | $90,940,000 | +31.2% | 12,406,613 | +16.7% | 0.00% | +50.0% |
| Q2 2022 | $69,307,000 | +56.3% | 10,629,996 | +21.1% | 0.00% | +100.0% |
| Q1 2022 | $44,332,000 | +167.3% | 8,778,702 | +309.6% | 0.00% | – |
| Q4 2021 | $16,588,000 | -49.3% | 2,143,088 | -3.2% | 0.00% | -100.0% |
| Q3 2021 | $32,749,000 | +15.3% | 2,212,819 | +26.5% | 0.00% | 0.0% |
| Q2 2021 | $28,410,000 | – | 1,749,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |